APA (7th ed.) Citation

Perin, E., Loveland, L., Caporusso, J., Dove, C., Motley, T., Sigal, F., . . . Armstrong, D. G. (2023). Gene therapy for diabetic foot ulcers: Interim analysis of a randomised, placebo‐controlled phase 3 study of VM202 (ENGENSIS), a plasmid DNA expressing two isoforms of human hepatocyte growth factor. International wound journal, 20(9), 3531-3539. https://doi.org/10.1111/iwj.14226

Chicago Style (17th ed.) Citation

Perin, Emerson, Lacey Loveland, Joseph Caporusso, Cyaandi Dove, Travis Motley, Felix Sigal, Mher Vartivarian, Francisco Oliva, and David G. Armstrong. "Gene Therapy for Diabetic Foot Ulcers: Interim Analysis of a Randomised, Placebo‐controlled Phase 3 Study of VM202 (ENGENSIS), a Plasmid DNA Expressing Two Isoforms of Human Hepatocyte Growth Factor." International Wound Journal 20, no. 9 (2023): 3531-3539. https://doi.org/10.1111/iwj.14226.

MLA (9th ed.) Citation

Perin, Emerson, et al. "Gene Therapy for Diabetic Foot Ulcers: Interim Analysis of a Randomised, Placebo‐controlled Phase 3 Study of VM202 (ENGENSIS), a Plasmid DNA Expressing Two Isoforms of Human Hepatocyte Growth Factor." International Wound Journal, vol. 20, no. 9, 2023, pp. 3531-3539, https://doi.org/10.1111/iwj.14226.